This volume provides a comprehensive overview of major advances and emerging directions in experimental and clinical cancer gene therapy. Covering both foundational technologies and next-generation therapeutic strategies, the book highlights significant progress in p53 replacement therapy, retroviral vector systems, and the engineering of chimeric antigen receptor (CAR) T cells. Additional chapters explore rapidly evolving areas including noncoding RNA therapeutics, miRNA-based approaches, mRNA cancer vaccines, suicide gene strategies, and gene correction technologies.
Particular emphasis is placed on the development of increasingly efficient and selective methods targeting both established and newly identified molecular pathways involved in tumor initiation, progression, and drug resistance, including ABCB1-mediated mechanisms. The volume also examines innovative therapeutic modalities such as bacterial toxin-based oncolytic therapies and the use of bacteria as targeted anticancer agents.
In parallel, the book details important advances in vector engineering, delivery systems, and overall therapeutic efficacy, linking laboratory research with translational and clinical applications. Collectively, these contributions provide readers with a broad and insightful perspective on the molecular technologies and therapeutic concepts shaping the future of cancer treatment.
When you click on links to various merchants on this site and make a purchase, this can result in this site earning a commission. Affiliate programs and affiliations include, but are not limited to, the eBay Partner Network.